Stocks › CGON
CG Oncology CGON
US equityMarket cap rank #1717
$79.47 −$2.43 (-2.97%)
Market closed · Nov 22, 5:50 am ET · Last extended-hours $79.50 +0.04%
Open$80.32
Prev close$81.90
Day range$79.21 – $83.16
Volume1.67M
Market cap$7.10B
P/E (TTM)–
Dividend yield–
CGON Stock News
Headlines matching CG Oncology or the CGON ticker, most recent first.
- Analysts' Top Healthcare Picks: CG Oncology, Inc. (CGON), Opus Genetics (IRD)
- Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating
- A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $85 to $108
- Bank of America Securities Reaffirms Their Buy Rating on CG Oncology, Inc. (CGON)
- Analysts' Top Healthcare Picks: Annexon Biosciences (ANNX), CG Oncology, Inc. (CGON)
- Analysts' Top Healthcare Picks: InflaRx (IFRX), CG Oncology, Inc. (CGON)
- A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $79 to $100
- CG Oncology, Inc. (CGON) Gets a Buy From Piper Sandler
- UBS Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $90
- UBS Keeps Their Buy Rating on CG Oncology, Inc. (CGON)
- Morgan Stanley Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $93
- Analysts' Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)
- Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $85
- H.C. Wainwright Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $100
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Phibro Animal Health (PAHC), Universal Health (UHS) and CG Oncology, Inc. (CGON)
No comments yet — be the first to weigh in on CGON.
Sign in to join the discussion.